NCT03072186

Brief Summary

This study is being done to demonstrate the feasibility of using a nasal endoscope to perform intraoperative angiography of surgical field, with the goals to evaluate anatomical landmarks and tumor characteristics during skull base surgery and publish a technical note.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 20, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 7, 2017

Completed
8 months until next milestone

Study Start

First participant enrolled

November 6, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2019

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2019

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

March 8, 2021

Completed
Last Updated

April 26, 2021

Status Verified

April 1, 2021

Enrollment Period

1.2 years

First QC Date

February 20, 2017

Results QC Date

May 5, 2020

Last Update Submit

April 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • ICG Fluorescence Ratio

    We aim to show that ICG fluorescence of the tumor intraoperatively is directly proportional to the contrast enhancement of the tumor from preoperative MRI. Enhancement is shown in ratio form on a scale of 0.01-1.00 showing enhancement ratios of 1. gland to internal carotid artery compared to blood fluorescence and 2. tumor tissue to blood fluorescence. Video recordings of intra-operative ICG fluorescence was compared to pre-operative imaging enhancements and compared in ratio format with a possible score of 0.01-1.00 The higher the ratio, the more closely the intra-operative fluorescence was related to the pre-operative imaging enhancements. 1.00 is considered to have the same enhancing brightness on pre-operative imaging as intra-operative video surveillance.

    Before intradural dissection and during tumor dissection.

Study Arms (1)

near-infrared light nasal endoscope used with ICG

EXPERIMENTAL

ICG will be administered to identify the blood supply at two distinct stages of endonasal cranial base surgery and tumor dissection: before intradural dissection and during tumor dissection.

Device: near-infrared light nasal endoscope used with ICG

Interventions

Using the near-infrared light nasal endoscope with ICG will identify anatomical landmarks and and tumor characteristics to provide a clear demonstration of the blood supply.

near-infrared light nasal endoscope used with ICG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and above
  • Patients undergoing an an EEA for cranial base pathology that will require any of the following will be eligible for the study: optic canal decompression, intradural tumor dissection, dissection of tumor around the internal carotid artery.

You may not qualify if:

  • Less than 18 years of age
  • History of sulfa, iodide, or penicillin allergy
  • Previous anaphylactic reaction to ICG
  • Women currently pregnant or nursing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Skull Base NeoplasmsSkull NeoplasmsBone NeoplasmsNeoplasmsBone DiseasesMusculoskeletal Diseases

Condition Hierarchy (Ancestors)

Neoplasms by Site

Results Point of Contact

Title
Dr. Daniel Prevedello, MD
Organization
Ohio State University Wexner Medical Center

Study Officials

  • Daniel Prevedello, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 20, 2017

First Posted

March 7, 2017

Study Start

November 6, 2017

Primary Completion

January 15, 2019

Study Completion

January 24, 2019

Last Updated

April 26, 2021

Results First Posted

March 8, 2021

Record last verified: 2021-04

Locations